All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis
Open Access
- 5 May 2022
- journal article
- research article
- Published by Elsevier in Genes & Diseases
- Vol. 9 (6) , 1742-1756
Abstract
No abstract availableKeywords
Funding Information
- Chongqing Municipal Science and Technology Bureau (cstc2021jcyj-msxmX0225)
- Chongqing Municipal Education Commission (KJQN201900442)
This publication has 59 references indexed in Scilit:
- Ferroptosis: process and functionCell Death & Differentiation, 2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitroInternational Journal of Oncology, 2015
- Uptake of L-cystine via an ABC transporter contributes defense of oxidative stress in the L-cystine export-dependent manner in Escherichia coliPLOS ONE, 2015
- The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cellsCancer Letters, 2015
- Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Nature Reviews Cancer, 2014
- Transcription Factor Nrf2-Mediated Antioxidant Defense System in the Development of Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2013
- Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenibInternational Journal of Cancer, 2013
- All Trans Retinoic Acid and CancerImmunopharmacology and Immunotoxicology, 2010
- Glutamate Cysteine Ligase (GCL) Transgenic and Gene‐Targeted Mice for Controlling Glutathione SynthesisCurrent Protocols in Toxicology, 2009